Consensus WuXi Biologics (Cayman) Inc. OTC Markets

Stocks

WXXW.Y

US98260N1081

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 03:59:59 2026-06-08 pm EDT			5-day change	1st Jan Change
7.780 ^USD	-4.89%		-10.37%	-2.75%

Jun. 05	Wuxi Biologics Completes Topping Out of Drug Product Facility At Singapore Crdmo Hub	CI
May. 31	Wuxi Biologics adds 69 projects in Jan-April, maintains expected revenue growth	RE

Evolution of the Average Target: WuXi Biologics (Cayman) Inc.

Evolution of the Target Price: WuXi Biologics (Cayman) Inc.

Changes in Analyst Recommendations: WuXi Biologics (Cayman) Inc.

d3d2870911e3ee0cbd3a7.lLQ3hCl0siGmJeqnG_yko-oRwwP5e0GcAhoPney1IDM._4wE824101XxTbLeU7DS7r5aijHNSSn9RVZQ-rPjYQbO927xcRWfR8sQow~bdcbfb7fda3e894409c6cb551927f587

Analysts' recommendations: WuXi Biologics (Cayman) Inc.

Nov. 28	Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$37.36 From HK$34.23, Keeps at Buy	MT
25-07-16	Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$34.23 From HK$34.36, Keeps at Buy	MT
25-03-31	Jefferies Adjusts WuXi Biologics (Cayman)'s Price Target to HK$45 From HK$35, Keeps at Buy	MT
25-03-26	Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$34.36 From HK$30.59, Keeps at Buy	MT
25-02-20	Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$30.59 From HK$19.30, Keeps at Buy	MT
25-02-04	UOB Kay Hian Upgrades Wuxi Biologics to Buy from Sell, Price Target is HK$23	MT
24-08-22	Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$19.30 From HK$23.25, Keeps at Buy	MT
24-07-24	Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$23.25 From HK$53.65, Keeps at Buy	MT
24-06-27	Bank of China Downgrades Wuxi Biologics (Cayman) to Hold From Buy, Price Target is HK$14	MT
24-03-01	Nomura Adjusts Wuxi Biologics' Price Target to HK$53.65 From HK$58.44, Keeps at Buy	MT
23-12-05	Nomura Adjusts Wuxi Biologics’ Price Target to HK$58.44 From HK$82.69, Keeps at Buy	MT
23-07-24	Nomura Adjusts Wuxi Biologics' Price Target to HK$82.69 From HK$86.68, Keeps at Buy	MT
23-06-21	Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$86.86 From HK$94.91, Keeps at Buy	MT
23-02-14	Nomura Adjusts WuXi Biologics' Price Target to HK$94.91 From HK$97.78, Keeps at Buy	MT
22-08-22	UBS Adjusts Wuxi Biologics’ Price Target to HK$113.12 From HK$110.67, Keeps at Buy	MT
22-08-05	Nomura Adjusts WuXi Biologics' Price Target to HK$97.78 From HK$95.75, Keeps at Buy	MT
22-06-08	UBS Adjusts Wuxi Biologics (Cayman)'s Price Target to HK$95.75 From HK$100.87, Keeps at Buy	MT
22-03-29	UBS Adjusts Wuxi Biologics' Price Target to HK$110.67 From HK$142, Keeps at Buy	MT
22-03-24	Nomura Adjusts WuXi Biologics' Price Target to HK$100.87 From HK$103.28, Keeps at Buy	MT
22-03-17	Nomura Adjusts WuXi Biologics' Price Target to HK$103.28 From HK$149.92, Keeps at Buy	MT
21-03-29	WUXI BIOLOGICS CAYMAN : Nomura Adjusts WuXi Biologics' Price Target to HK$116.8 From HK$213.1, Keeps at Buy	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ARGENX SE					+10.53%
	WUXI APPTEC CO., LTD.					+51.16%
	BIONTECH SE					+40.53%
	INSMED INCORPORATED					+111.76%
	GENMAB A/S					+46.08%
	EXELIXIS, INC.					-5.79%
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.					+39.21%
	SUMMIT THERAPEUTICS INC.					+92.65%
	MADRIGAL PHARMACEUTICALS, INC.					+39.49%
	Average					+47.29%
	Weighted average by Cap.					+42.03%